NEW YORK (GenomeWeb) – Molecular diagnostics firm Multiplicom announced today that it has received a €1.9 million ($2.1 million) grant from the Belgian government to support its development of technologies and next-generation sequencing tests for cancer diagnosis, treatment, and monitoring.

Multiplicom said that the funded work will be conducted in collaboration with VIB Laboratory of Translational Genetics, Vesalius Research Centre, KULeuven, University Hospital Leuven, and Antwerp University Hospital.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.